OTLK Earnings Outlook Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q2 2026 | 2026-03-31 | -0.39 | 2026-05-15 | 10-Q |
| Q1 2026 | 2025-12-31 | -0.38 | 2026-02-17 | 10-Q |
| FY 2025 | 2025-09-30 | -1.79 | 2025-12-19 | 10-K |
| Q3 2025 | 2025-06-30 | -1.60 | 2025-08-14 | 10-Q |
| Q2 2026 | 2025-03-31 | -1.05 | 2026-05-15 | 10-Q |
| Q1 2026 | 2024-12-31 | 0.72 | 2026-02-17 | 10-Q |
| FY 2025 | 2024-09-30 | -4.06 | 2025-12-19 | 10-K |
| Q3 2025 | 2024-06-30 | -4.82 | 2025-08-14 | 10-Q |
| Q2 2025 | 2024-03-31 | -9.20 | 2025-05-15 | 10-Q |
| Q1 2025 | 2023-12-31 | -0.86 | 2025-02-14 | 10-Q |
| FY 2024 | 2023-09-30 | -4.72 | 2024-12-27 | 10-K |
| Q3 2024 | 2023-06-30 | -3.73 | 2024-08-14 | 10-Q |
| Q2 2024 | 2023-03-31 | -2.09 | 2024-05-15 | 10-Q |
| Q1 2024 | 2022-12-31 | -0.08 | 2024-02-14 | 10-Q |
| FY 2023 | 2022-09-30 | -0.31 | 2023-12-22 | 10-K |
| Q3 2023 | 2022-06-30 | -0.25 | 2023-08-14 | 10-Q |
| Q2 2023 | 2022-03-31 | -0.17 | 2023-05-15 | 10-Q |
| Q1 2023 | 2021-12-31 | -0.08 | 2023-02-14 | 10-Q |
| FY 2022 | 2021-09-30 | -0.35 | 2022-12-29 | 10-K |
| Q3 2022 | 2021-06-30 | -0.27 | 2022-08-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.